Acquisition momentum InquisitHealth was acquired by Pyx Health for 47.5M in early 2024, indicating a strong exit event and potential integration opportunities with Pyx Health’s platform, which may open cross-sell or partnership avenues.

Peer workforce value Leverage their tech-enabled remote community health workers to engage struggling patients and address social determinants of health, presenting a compelling value proposition for health plans, systems, and employers seeking scalable social care solutions.

Strategic partnerships Past collaborations with NYC Health + Hospitals and ViiV Healthcare demonstrate a track record of working with large health systems and disease-specific programs, suggesting a path to contract expansion with large payers or integrated delivery networks.

MaaS and disease focus Portfolio includes disease management as a service for hypertension, diabetes, sickle cell, and breast cancer, enabling targeted upsell into chronic disease programs and specialized care pathways for health plans and providers.

Financial and scale signals Revenue in the low mid single digits with modest funding, but active growth through acquisitions and expansion suggests opportunity to grow ARR with scaled deployments, especially in organizations already investing in population health and social determinants.